-
Product Insights
Medullary Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Medullary Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Medullary thyroid cancer (MTC) is a rare and aggressive type of thyroid cancer that originates from the C cells, which produce calcitonin, a hormone that regulates calcium levels in the blood. MTC accounts for 5-10% of all thyroid cancers and can be sporadic or inherited. Sporadic MTC occurs randomly, while inherited MTC is associated with a genetic condition called multiple endocrine...
-
Product Insights
Metastatic Liver Cancer - Drugs In Development, 2024
Empower your strategies with our Metastatic Liver Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Metastatic liver cancer is a condition where cancer cells from another part of the body spread to the liver. The liver is a vital organ that performs many functions, such as filtering toxins, producing bile, and storing glycogen. Metastatic liver cancer can affect these functions and cause symptoms such as pain, jaundice, weight loss, and swelling. The most common cancers that...
-
Product Insights
Colon Carcinoma - Drugs In Development, 2024
Empower your strategies with our Colon Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Colon carcinoma is a type of cancer that affects the large intestine, which includes the colon and the rectum. It is one of the most common cancers worldwide and can cause symptoms such as blood in the stool, weight loss, and fatigue. Colon carcinoma usually develops from benign growths called polyps that form on the inner lining of the colon or rectum....
-
Product Insights
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) - Drugs In Development, 2024
Empower your strategies with our Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) – Drugs In Development, 2024 report and make more profitable business decisions. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous group of neoplasms that originate from neuroendocrine cells in the gastrointestinal tract and pancreas. These cells produce hormones that regulate various functions in the body. GEP-NETs can be classified as functional or non-functional, depending on whether they secrete excess hormones or not. Functional GEP-NETs can cause various syndromes, such as carcinoid...
-
Product Insights
Muscle Invasive Bladder Cancer (MIBC) - Drugs In Development, 2024
Empower your strategies with our Muscle Invasive Bladder Cancer (MIBC) – Drugs In Development, 2024 report and make more profitable business decisions. Muscle invasive bladder cancer (MIBC) is a type of bladder cancer that has grown into the muscle wall of the bladder, making it more likely to spread to other parts of the body. It accounts for about 25% of bladder cancers and has a poor prognosis. The main risk factor for MIBC is smoking, but other factors such as...
-
Product Insights
Thymic Carcinoma - Drugs In Development, 2024
Empower your strategies with our Thymic Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Thymic carcinoma is a rare and aggressive cancer that originates from the epithelial cells of the thymus, a gland in the chest that produces immune cells. Thymic carcinoma often spreads to other organs and is resistant to chemotherapy. The symptoms may include chest pain, cough, difficulty breathing, and weight loss. The diagnosis is based on imaging tests and biopsy of the tumor...
-
Product Insights
Adrenal Gland Cancer - Drugs In Development, 2024
Empower your strategies with our Adrenal Gland Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Adrenal gland cancer is a rare type of neuroendocrine tumor that originates from the cells of the adrenal glands, which are located on top of the kidneys. The adrenal glands produce hormones that regulate various functions in the body, such as blood pressure, metabolism, stress response, and sex drive. Adrenal gland cancer can affect the production of these hormones, causing symptoms...
-
Product Insights
Anaplastic Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Anaplastic Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Anaplastic thyroid cancer (ATC) is a rare and aggressive form of thyroid cancer that affects mainly older people. It grows very fast and often spreads to other parts of the body, such as the lungs, bones, and brain. It causes symptoms like a large and painful neck mass, difficulty swallowing or breathing, hoarseness, and cough. The cause of ATC is unknown,...
-
Product Insights
Cancer Anorexia-Cachexia Syndrome - Drugs In Development, 2024
Empower your strategies with our Cancer Anorexia-Cachexia Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Cancer anorexia-cachexia syndrome is defined as progressive weight loss associated with malignancy and is characterized by loss of appetite (anorexia), skeletal muscle wasting, and reduced adipose tissue. Approximately 50% of cancer patients report abnormalities of eating behavior at the time of first diagnosis and prevalence is even higher at approximately 65%. The incidence of weight loss upon diagnosis varies greatly according...
-
Product Insights
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Drugs In Development, 2024
Empower your strategies with our Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) – Drugs In Development, 2024 report and make more profitable business decisions. Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas that originate from peripheral nerves or from cells associated with the nerve sheath, such as Schwann cells, perineural cells, or fibroblasts. Symptoms include a lump or swelling in the in the soft tissue, numbness, burning, tingling or pins and needles, weakness of the affected muscles, and dizziness or loss of balance....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.